Stay updated on Pembrolizumab Combo in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in mCRPC Clinical Trial page
- CheckyesterdayChange DetectedThe page’s footer was updated to reflect a new ClinicalTrials.gov interface/revision version (v3.5.3 instead of v3.5.2). This is a platform/version display change rather than a change to the trial information.SummaryDifference0.0%

- Check8 days agoChange DetectedAdded Temuco (Araucania) and Viña del Mar (Valparaiso) as Chilean sites and removed the 'Región de' prefixes to standardize regional names.SummaryDifference0.3%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedLocation entry changed from Napoli, Italy, 80131 to Naples, Italy, 80131, and the page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded revision note v3.4.3 and removed v3.4.2 from the page.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision: v3.4.2 is now displayed, replacing the former v3.4.1. This update does not modify the study content or how users interact with the page.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page. This is a minor version update and does not affect study content, eligibility criteria, outcomes, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.